The increasing number of sport-related injuries is expected to drive the Global Tendonitis Treatment Market in the forecast period, 2024-2028.
According to TechSci Research report, “Tendonitis Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, the global tendonitis treatment market is anticipated to grow at an impressive rate in the forecast period, 2024-2028. This can be ascribed to the rising prevalence of bone-related disorders like arthritis also diabetes along with the enhancement of novel technologies, and therapies for the treatment of tendonitis across the globe. Similarly, increased funding from government organizations for the development of healthcare infrastructure and other large investments by some big corporations in the medical field, will boost the growth of opportunities in the market, in the forecast period. Additionally, the increasing number of older population across the globe and development of better healthcare for the treatment of bone related injuries is further expected to increase the demand for the tendonitis treatment market during the forecast period. Similarly, a major population is inclined toward noninvasive therapies or surgeries for the treatment of bone injuries with sudden injuries due to trauma is expected to create lucrative growth during the forecast period. Besides, due to not maintain healthy lifestyle such as repetitive forces, such as those caused by running, can cause stress fractures of the foot, ankle, tibia, or hip, trauma, falls from height, motor vehicle accidents are the main factors which will boost the growth of the market during the forecast period.
However, increasing side effects associated with treatments and the recurrent nature of the injuries, may hamper the global tendonitis treatment market in the forecast period. Similarly, ineffective and less prompt treatments combined with a lack of efficacy related to treatments, can restrict the growth of the global tendonitis treatment market in the forecast period. Additionally, travel restrictions due to the pandemic and increased infection load in the medical sector can restrict the growth of the market during the forecast period.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on “Tendonitis Treatment Market“
The Global Tendonitis Treatment market is segmented by therapy, by condition and by region.
Based on Condition, the global tendonitis treatment market can be segmented into Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, and Others. The tennis elbow segment is expected to dominate the market in 2022 and maintain its dominance throughout the forecast period. The increasing prevalence of lateral elbow tendinopathy and medial elbow tendinopathy across the globe along with the growing aging population is expected to boost the market growth during the forecast period. Similarly, increasing demand for lifestyle changes with some physical activity ,which can include different sports activities causing injuries, will further propel the market in the forecast period.
Based on Therapy, the global tendonitis treatment market can be divided into Therapy and Surgery. The surgery segment is expected to dominate the market in 2022 and maintain its dominance throughout the forecast period. This can be ascribed to increasing sport-related injuries with increasing demand for sports activities across the globe. Similarly, the increasing demand for maintaining a healthy lifestyle is also propelling the growth of the market. Also, the growing demand for minimally invasive surgeries for the treatment of tendonitis is expected to create significant growth during the forecast period.
Major companies operating in the global tendonitis treatment market are:
- Merck and Co. Inc.
- Bayer AG
- AstraZeneca Plc.
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Abbott Laboratories, Inc.
- Pfizer, Inc.
- GlaxoSmithKline PLC
- Almatica Pharma, Inc.
In March 2017,RepliCel OLife Sciences completed the phase I human clinical study of RCT-01, a cell therapy for the treatment of patients with injured Achiles tendon. An exoskeleton knee brace that is about 30% lighter than standard models was developed by Delsson, a Singapore-based engineering firm, in partnership with 3D printing experts at Nanyang Technological University (NTU) in Singapore, in December 2021.
Customers can also request for 10% free customization on this report.
“North America is expected to register the highest growth in the global tendonitis treatment market on account of increasing collaboration between pharmaceutical companies to develop new therapies for the treatment of bone-related injuries across the region. Similarly, the growing government funds for research and development of bone disorder in the healthcare sector along with the rapid adoption of new therapies can further propel the market growth during the forecast period. Additionally, the growing aging population pool susceptible for bone injuries due to osteoporosis, arthritis along with constantly improving healthcare infrastructure is expected to drive the demand for the tendonitis treatment market in the forecast period. Similarly, the growing industry of medical tourism is expected to propel the market growth till 2028” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Tendonitis Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Therapy (Therapy v/s Surgery), By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others) and By Region”, has evaluated the future growth potential of the global tendonitis treatment market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the global tendonitis treatment market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com
